Since LOC101927668 expression remained consistent in CRC patients regardless of KRAS and BRAF mutation status (Fig. S13A), we investigated several transcription factors, including MACC1, E2F3, and SIX2, known for their oncogenic roles in CRC tumorigenesis [66–68]. The gene discussed is SIX2; the disease is colorectal carcinoma.